Загрузка...
Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction
Although cell therapy-mediated cardiac repair offers promise for treatment/management of heart failure, lack of fundamental understanding of how cell therapy works limits its translational potential. In particular, whether reparative cells from failing hearts differ from cells derived from nonfailin...
Сохранить в:
| Опубликовано в: : | Am J Physiol Heart Circ Physiol |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Physiological Society
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7474443/ https://ncbi.nlm.nih.gov/pubmed/32442025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00114.2020 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|